Carmel Wroth
Carmel Wroth is a senior health editor for NPR's Science Desk, where she guides digital strategy for the health team and conceives and edits digital-first, enterprise stories and packages.
Formerly, she founded and managed Side Effects Public Media, a public radio collaborative covering public health in the Midwest. Wroth also served as an editor at Yoga Journal for five years.
-
With the back and forth on boosters from government agencies, many Americans are wondering if they really need an extra shot. Here is what the science says about who needs a booster now — and why. -
Though infections are still sky-high, the U.S. may be turning a corner, according to a consortium of researchers who forecast the pandemic. And we may well be spared a winter surge. -
If all goes to plan, Americans who got Pfizer or Moderna shots can get a third dose eight months after their last jab. Here's why health officials think you'll need one. -
People with weakened immune systems who already got two doses of the Pfizer or Moderna COVID-19 vaccines can now get a third shot. But exactly who is eligible? Here's what we know so far. -
The highly contagious delta variant of the coronavirus is spreading fast and driving new cases and hospitalizations. Here's what you need to know to keep yourself and your kids from getting sick. -
As the delta variant takes over in the U.S., new, localized outbreaks are emerging. Those surges are likely driven by pockets of dangerously low vaccination rates.
-
Can I get a massage? Travel with my unvaccinated kids? Eat indoors at a restaurant? Hit the gym? Experts weigh in with advice on 16 frequently asked post-vaccination questions. -
President-Elect Joe Biden shares details of how his administration hopes to tackle the country's public health crisis. It's an aggressive plan that he needs Congress to fund. -
Many favorite holiday traditions could be treacherous this year because of the coronavirus. Here's how experts view the risks — and some creative, safer alternatives to keep up a festive mood. -
An independent federal advisory committee to the CDC recommends the Pfizer-BioNTech vaccine for people over 16. But state health leaders say distribution and funding challenges remain.
